Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis

Completed 25 enrolled FDA Office of Orphan Products Development Vanderbilt University · collab

RandomizedCrossoverDouble-blindTreatment

Summary

OBJECTIVES: I. Assess the clinical safety and long term effects of recombinant human growth hormone on a defined range of nutritional indices in malnourished chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.

Timeline

Start: 1999-12
Primary completion: —
Completion: 2005-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Somatropin	Protein / enzyme biologic	—	Subcutaneous

Randomized Study of Recombinant Human Growth Hormone in Patients on Chronic Hemodialysis or Peritoneal Dialysis

Summary

Timeline

Drugs

Indications